Prescribing overview
Lasix is a potent human diuretic for edema and hypertension. Excess diuresis can profoundly deplete fluid and electrolytes; a patient’s fluid status and kidney function determine whether additional diuresis is appropriate.
Key prescribing checks
- The human label contraindicates use in anuria and furosemide hypersensitivity. Absent urine production requires clinical evaluation, not an assumption that more diuretic is needed.
- Monitor hydration, body weight, blood pressure, kidney values and electrolytes within the veterinarian’s plan. Excessive diuresis can cause dehydration and electrolyte depletion.
- Reconcile other diuretics, ACE inhibitors, NSAIDs and drugs with renal or hearing-related risks before treatment changes.
- Worsening breathing or collapse is an urgent clinical problem; a medication identity lookup is not an emergency dosing instruction.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Humans (reference label)
Human Lasix label; no veterinary regimen verified hereEdema associated with cardiac, hepatic or renal disease; hypertension
This summary does not cover a veterinary furosemide product.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Inhibits sodium/chloride reabsorption, prominently in the loop of Henle.
Absorption, distribution, metabolism and elimination
Fasted human men: tablet bioavailability averaged 64% relative to intravenous dosing; human terminal half-life approximately 2 hours. Not animal estimates.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Lasix
U.S. human oral-tablet label; not veterinary approval.
Contraindications · when not to use
- Anuria; prior furosemide hypersensitivity.
Precautions & monitoring
- Correct electrolyte depletion and hepatic coma before starting; monitor dehydration, kidney function and electrolytes.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Dehydration, hypotension, electrolyte depletion and ototoxicity; contraindicated with anuria.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
No approved veterinary dose verified from the reviewed human Lasix label.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Lasix
U.S. human oral-tablet label; not veterinary approval.
- Review aminoglycosides/other ototoxic agents, lithium, ACE inhibitors/ARBs and sucralfate.
Monitoring
Assess weight/fluid status, blood pressure, renal values and electrolytes; review ototoxic agents, NSAIDs and renin–angiotensin drugs.
Client counseling
Report weakness, thirst, reduced urine or other suspected excessive diuresis; do not independently escalate treatment.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Use the dispensed formulation’s storage instructions; protect tablets from light.
Brands, formulations & ingredient identity
Active ingredients
furosemide
Lasix maps to furosemide. It is not torsemide or spironolactone, which are separate diuretics with different properties and clinical instructions.
The cited Lasix label describes oral tablets. Injectable products and other veterinary formulations need separate route and concentration checks.
A brand synonym helps identify the drug but cannot establish whether a patient needs more or less diuresis. Record the actual product rather than only the intended effect.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Lasix
- Formulation
- Oral tablets
- Label / product scope
- Human product
Human furosemide brand; check formulation and veterinary prescription.
Product label / source ↗References & review status
Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →